Published in Clin Colon Rectal Surg on May 01, 2009
Endobronchial metastasis from primary anorectal melanoma. Am J Case Rep (2013) 1.09
Anal versus rectal melanoma: does site of origin predict outcome? Dis Colon Rectum (2013) 0.97
Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol (2013) 0.81
Malignant melanoma of the rectum. J Clin Imaging Sci (2014) 0.79
Primary anorectal malignant melanoma treated with endoscopic mucosal resection. Intest Res (2015) 0.79
Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95
Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center. Dis Colon Rectum (1995) 2.64
Anorectal melanoma--an incurable disease? Dis Colon Rectum (1997) 2.02
The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg (2006) 1.90
Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst Rev (2000) 1.88
Incidence of noncutaneous melanomas in the U.S. Cancer (2005) 1.85
Anorectal melanoma. Cancer (1981) 1.77
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer (2007) 1.76
Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Cancer (1999) 1.70
Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol (2002) 1.65
Surgical therapy for anorectal melanoma. J Am Coll Surg (2003) 1.65
Changing epidemiology of anorectal melanoma. Dis Colon Rectum (1999) 1.51
Radiation biology of malignant melanoma. Acta Radiol Oncol (1986) 1.17
The surgical treatment of anorectal malignant melanoma. Br J Surg (1986) 1.12
Clinical radiobiology of malignant melanoma. Radiother Oncol (1989) 1.07
Response of stage IV anal mucosal melanoma to chemotherapy. Lancet Oncol (2005) 1.04
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol (2008) 2.27
Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Lett (2006) 2.12
The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg (2006) 1.90
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer (2007) 1.76
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol (2014) 1.76
c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases. Cancer Lett (2008) 1.71
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg (2005) 1.64
Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol (2014) 1.59
Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg (2012) 1.58
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol (2004) 1.58
Anastomotic leak is not associated with oncologic outcome in patients undergoing low anterior resection for rectal cancer. Ann Surg (2012) 1.57
Effects of obesity in rectal cancer surgery. J Am Coll Surg (2010) 1.56
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol (2008) 1.54
Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum (2008) 1.53
Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer (2008) 1.53
HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells. Mol Cancer Ther (2008) 1.52
HGF rescues colorectal cancer cells from EGFR inhibition via MET activation. Clin Cancer Res (2010) 1.50
T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg (2005) 1.49
Feasibility of ex vivo FDG PET of the colon. Radiology (2009) 1.43
MET expression and amplification in patients with localized gastric cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.42
MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells. Mol Cancer Ther (2012) 1.40
The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum (2005) 1.37
Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer (2010) 1.34
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer. Cancer (2014) 1.32
Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum (2005) 1.26
Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis. J Natl Compr Canc Netw (2009) 1.25
Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessment. Ann Surg Oncol (2007) 1.24
Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg (2004) 1.21
Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum (2009) 1.20
Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum (2007) 1.20
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol (2005) 1.16
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance. Hum Pathol (2008) 1.14
Whither TNM? Semin Oncol (2010) 1.11
Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol (2002) 1.06
Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum (2008) 1.06
Response of stage IV anal mucosal melanoma to chemotherapy. Lancet Oncol (2005) 1.04
Combined CT colonography and 18F-FDG PET of colon polyps: potential technique for selective detection of cancer and precancerous lesions. AJR Am J Roentgenol (2007) 1.03
Quality of life and symptom control after stent placement or surgical palliation of malignant colorectal obstruction. J Am Coll Surg (2010) 1.03
Immunoblot analysis of c-Met expression in human colorectal cancer: overexpression is associated with advanced stage cancer. Clin Exp Metastasis (2004) 1.02
Impact of a temporary stoma on the quality of life of rectal cancer patients undergoing treatment. Ann Surg Oncol (2010) 1.02
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Canc Netw (2014) 1.01
Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis. J Clin Oncol (2012) 1.01
Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy. Am J Surg Pathol (2011) 1.01
Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol (2011) 1.01
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum (2004) 1.00
Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis. Radiother Oncol (2013) 1.00
Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel. Am J Surg Pathol (2009) 0.99
What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy? Ann Surg Oncol (2013) 0.99
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study. Ann Surg (2012) 0.99
Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Ann Surg Oncol (2011) 0.98
A predictive model for lymph node yield in colon cancer resection specimens. Ann Surg (2011) 0.98
Novel xenograft model expressing human hepatocyte growth factor shows ligand-dependent growth of c-Met-expressing tumors. Mol Cancer Ther (2007) 0.98
Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis. Ann Surg Oncol (2011) 0.97
Anal versus rectal melanoma: does site of origin predict outcome? Dis Colon Rectum (2013) 0.97
Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum (2007) 0.97
Factors associated with sphincter-preserving surgery for rectal cancer at national comprehensive cancer network centers. Ann Surg (2009) 0.96
Nodal staging score: a tool to assess adequate staging of node-negative colon cancer. J Clin Oncol (2009) 0.96
Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance. Mod Pathol (2011) 0.95
Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum (2006) 0.94
Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance. Hum Pathol (2007) 0.93
Complications after preoperative combined modality therapy and radical resection of locally advanced rectal cancer: a 14-year experience from a specialty service. J Am Coll Surg (2005) 0.93
Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples? Am J Surg Pathol (2011) 0.92
Surgical management of locally advanced and locally recurrent colon cancer. Clin Colon Rectal Surg (2005) 0.92
An update on laparoscopic resection for rectal cancer. Cancer Control (2010) 0.90
Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment. Ann Surg Oncol (2006) 0.89
Irreversible electroporation adjacent to the rectum: evaluation of pathological effects in a pig model. Cardiovasc Intervent Radiol (2012) 0.89
Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention. Ann Surg Oncol (2008) 0.88
Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases. Ann Surg Oncol (2012) 0.88
Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition. Clin Cancer Res (2011) 0.88
Rate of residual disease after complete endoscopic resection of malignant colonic polyp. Dis Colon Rectum (2012) 0.87
Treatment of locally advanced rectal cancer: controversies and questions. World J Gastroenterol (2012) 0.86
Endorectal ultrasound: its role in the diagnosis and treatment of rectal cancer. Clin Colon Rectal Surg (2008) 0.84
Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument? Ann Surg Oncol (2007) 0.84
Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor? Dis Colon Rectum (2015) 0.83
Anastomotic leak following low anterior resection in stage IV rectal cancer is associated with poor survival. Ann Surg Oncol (2013) 0.83
Evaluation of an endorectal electrode for performing focused irreversible electroporation ablations in the Swine rectum. J Vasc Interv Radiol (2013) 0.83
Rectal cancer trials: no movement. J Clin Oncol (2011) 0.82
Locoregional lymphadenectomy in the surgical management of anorectal melanoma. Ann Surg Oncol (2013) 0.81
Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case. Fam Cancer (2015) 0.81
Patterns of failure in patients with early onset (synchronous) resectable liver metastases from rectal cancer. Cancer (2012) 0.80
Accuracy of endorectal ultrasound for measurement of the closest predicted radial mesorectal margin for rectal cancer. Dis Colon Rectum (2012) 0.80
Does endoscopic ultrasound improve detection of locally recurrent anal squamous-cell cancer? Dis Colon Rectum (2015) 0.80
Progress in the PROSPECT trial: precision treatment for rectal cancer? Bull Am Coll Surg (2015) 0.80
Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation. Ann Surg Oncol (2007) 0.80
Predictive clinicopathologic factors for limited response of T3 rectal cancer to combined modality therapy. Int J Colorectal Dis (2007) 0.79
Randomized clinical trials in rectal and anal cancers. Surg Oncol Clin N Am (2010) 0.79
Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis. Dis Colon Rectum (2009) 0.79
Does gadolinium-based contrast material improve diagnostic accuracy of local invasion in rectal cancer MRI? A multireader study. AJR Am J Roentgenol (2015) 0.78
Prevalence of perianal intraepithelial neoplasia in HIV-infected patients referred for high-resolution anoscopy. Dis Colon Rectum (2006) 0.78
Robotic colorectal surgery. J Gastrointest Surg (2013) 0.78
Surgery and high-dose-rate intraoperative radiation therapy for recurrent squamous-cell carcinoma of the anal canal. Dis Colon Rectum (2011) 0.78
Clinical Practice Guidelines for the Surgical Treatment of Patients With Lynch Syndrome. Dis Colon Rectum (2017) 0.77
Neoadjuvant radiation therapy prior to total mesorectal excision for rectal cancer is not associated with postoperative complications using current techniques. Ann Surg Oncol (2014) 0.77
Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome. Ann Surg (2012) 0.77
Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma. Ann Surg Oncol (2015) 0.77
Response to neoadjuvant therapy in patients with early age-of-onset rectal cancer. Dis Colon Rectum (2013) 0.77
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis. Dis Colon Rectum (2012) 0.76
Prospective immunohistochemical analysis of primary colorectal cancers for loss of mismatch repair protein expression. Clin Colorectal Cancer (2010) 0.76
Outcomes in non-metastatic colorectal cancer. J Surg Oncol (2014) 0.75